Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes

Pharmaceutical Research

Volumn 17, Issue 6, 2000, Pages 720-726

  van Rensen, Annemiek J M L ^a,b   Taams, Leonie S ^b   Grosfeld Stulemeyer, Mayken C ^b   van Eden, Willem ^b   Crommelin, Daan J A ^a   Wauben, Marca H M ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Anergy; Antigen presentation; Liposomes; MHC; T lymphocytes

Indexed keywords

DRUG CARRIER; LIPOSOME; PEPTIDE;

ACCESSORY CELL; ANTIGEN PRESENTATION; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW CYTOMETRY; IMMUNOTHERAPY; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DIVISION; CLONAL ANERGY; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIPOSOMES; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0033848558     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007586400631     Document Type: Article

References (30)

1. T-cell recognition of antigen and the la molecule as a ternary complex
2. T cell activation determined by T cell receptor number and tunable thresholds
3. The immunological synapse: A molecular machine controlling T cell activation
4. Models of T cell anergy: Is there a common molecular mechanism?
5. Anergic T cells actively suppress T cell responses via the antigen presenting cell
6. Antigen presentation by chemically modified splenocytes which induces antigen-specific T cell unresponsiveness in vitro and in vivo
7. Stimulation of normal inducer T cell clones with antigen presented by purified la molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonresponsiveness
8. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes
9. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness
10. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells
11. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
12. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1
13. Anergic T cells as suppressor cells in vitro
14. Serial triggering of TCRs: A basis for the sensitivity and specificity of antigen recognition
15. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes
16. Phenotypic analysis of antigen-specific T lymphocytes
17. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes
18. Antigen presentation by supported planar membranes containing affinity-purified I-Ad
19. Liposomes with incorporated MHC class II/peptide complexes as antigen-presenting vesicles for specific T cell activation
20. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
21. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents
22. Arthritis induced in rats by cloned T lymphocytes responsive to Mycobacteria but not to collagen type II
23. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation)
24. Activated rat T cells synthesize and express functional major histocompatibility class II antigens
25. Stimulation of T cells by antigenic peptide complexes with isolated chains of major histocompatibility complex class II molecules
26. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
27. Serial triggering of many T-cell receptors by a few peptide-MHC complexes
28. Agonist-induced T cell receptor down-regulation: Molecular requirements and dissociation from T cel activation
29. Liposomes: Quo vadis?